Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Change in Inventory (2020 - 2025)

Historic Change in Inventory for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to -$9.0 million.

  • Sotera Health's Change in Inventory fell 8597.0% to -$9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.8 million, marking a year-over-year decrease of 11857.26%. This contributed to the annual value of $4.8 million for FY2024, which is 5233.65% down from last year.
  • Per Sotera Health's latest filing, its Change in Inventory stood at -$9.0 million for Q3 2025, which was down 8597.0% from -$4.2 million recorded in Q2 2025.
  • Sotera Health's 5-year Change in Inventory high stood at $16.8 million for Q4 2021, and its period low was -$9.3 million during Q1 2022.
  • In the last 5 years, Sotera Health's Change in Inventory had a median value of -$545000.0 in 2022 and averaged $1.0 million.
  • Over the last 5 years, Sotera Health's Change in Inventory had its largest YoY gain of 177082.57% in 2023, and its largest YoY loss of 269568.97% in 2023.
  • Quarter analysis of 5 years shows Sotera Health's Change in Inventory stood at $16.8 million in 2021, then tumbled by 103.24% to -$545000.0 in 2022, then soared by 1770.83% to $9.1 million in 2023, then crashed by 116.14% to -$1.5 million in 2024, then tumbled by 514.97% to -$9.0 million in 2025.
  • Its Change in Inventory stands at -$9.0 million for Q3 2025, versus -$4.2 million for Q2 2025 and $11.8 million for Q1 2025.